Oral contraceptives and cardiovascular disease (first of two parts).
D000017:ABO Blood-Group System / Q000032:analysis; D020152:Antithrombin III Deficiency; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D005342:Fibrinolysis; D006801:Humans; D011372:Progestins / Q000009:adverse effects; D013923:Thromboembolism / Q000139:chemically induced
D000017:ABO Blood-Group System; D003276:Contraceptives, Oral; D003278:Contraceptives, Oral, Hormonal; D004967:Estrogens; D011372:Progestins